AGM/EGMApr 29, 2026, 08:12 AM
CMPX 2026 Annual Meeting to Elect Directors, Vote on Exec Comp
AI Summary
Compass Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, at 9:00 a.m. Eastern Time. Stockholders will vote on the election of two Class III directors, the ratification of CohnReznick LLP as the independent auditor for 2026, and advisory votes on executive compensation and its frequency. The company also highlighted recent executive appointments, including Arjun Prasad as Chief Commercial Officer and Cynthia Sirard as Chief Medical Officer in January 2026.
Key Highlights
- CMPX 2026 Annual Meeting on June 10, 2026, at 9:00 a.m. ET.
- Stockholders of record as of April 15, 2026, to vote 180,087,915 shares.
- Proposals include election of two Class III directors.
- Ratification of CohnReznick LLP as 2026 independent auditor.
- Advisory vote on named executive officer compensation.
- Advisory vote on frequency (1, 2, or 3 years) for future compensation votes.
- Arjun Prasad appointed Chief Commercial Officer in January 2026.
- Cynthia Sirard appointed Chief Medical Officer in January 2026.
Price Impact
More from CMPX